BETHLEHEM, Pa.--(BUSINESS WIRE)--Neuromonics Inc. today announced publication of the first clinical study evaluating the Neuromonics Tinnitus Treatment’s effectiveness compared to relevant control groups. Published in the June 15 issue of ENT Journal, the study demonstrates that patients receiving Neuromonics Tinnitus Treatment reported significantly greater improvements in tinnitus disturbance than those receiving an equivalent rehabilitation and counseling program with broadband noise acoustic stimulus or no acoustic stimulation. Broadband noise, a traditional approach designed to “mask” the tinnitus, did not significantly improve tinnitus disturbance compared to the counseling-only group. Only the Neuromonics Tinnitus Treatment demonstrated significant improvements over time.
